Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

被引:9128
|
作者
Go, AS
Chertow, GM
Fan, DJ
McCulloch, CE
Hsu, CY
机构
[1] Kaiser Permanente No Calif, Div Res, Oakland, CA 94612 USA
[2] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2004年 / 351卷 / 13期
关键词
D O I
10.1056/NEJMoa041031
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: End-stage renal disease substantially increases the risks of death, cardiovascular disease, and use of specialized health care, but the effects of less severe kidney dysfunction on these outcomes are less well defined. Methods: We estimated the longitudinal glomerular filtration rate (GFR) among 1,120,295 adults within a large, integrated system of health care delivery in whom serum creatinine had been measured between 1996 and 2000 and who had not undergone dialysis or kidney transplantation. We examined the multivariable association between the estimated GFR and the risks of death, cardiovascular events, and hospitalization. Results: The median follow-up was 2.84 years, the mean age was 52 years, and 55 percent of the group were women. After adjustment, the risk of death increased as the GFR decreased below 60 ml per minute per 1.73 m(2) of body-surface area: the adjusted hazard ratio for death was 1.2 with an estimated GFR of 45 to 59 ml per minute per 1.73 m(2) (95 percent confidence interval, 1.1 to 1.2), 1.8 with an estimated GFR of 30 to 44 ml per minute per 1.73 m(2) (95 percent confidence interval, 1.7 to 1.9), 3.2 with an estimated GFR of 15 to 29 ml per minute per 1.73 m(2) (95 percent confidence interval, 3.1 to 3.4), and 5.9 with an estimated GFR of less than 15 ml per minute per 1.73 m(2) (95 percent confidence interval, 5.4 to 6.5). The adjusted hazard ratio for cardiovascular events also increased inversely with the estimated GFR: 1.4 (95 percent confidence interval, 1.4 to 1.5), 2.0 (95 percent confidence interval, 1.9 to 2.1), 2.8 (95 percent confidence interval, 2.6 to 2.9), and 3.4 (95 percent confidence interval, 3.1 to 3.8), respectively. The adjusted risk of hospitalization with a reduced estimated GFR followed a similar pattern. Conclusions: An independent, graded association was observed between a reduced estimated GFR and the risk of death, cardiovascular events, and hospitalization in a large, community-based population. These findings highlight the clinical and public health importance of chronic renal insufficiency.
引用
收藏
页码:1296 / 1305
页数:10
相关论文
共 50 条
  • [21] Endothelial function and cardiovascular events in chronic kidney disease
    Hirata, Yoshihiro
    Sugiyama, Seigo
    Yamamoto, Eiichiro
    Matsuzawa, Yasushi
    Akiyama, Eiichi
    Kusaka, Hiroaki
    Fujisue, Koichiro
    Kurokawa, Hirofumi
    Matsubara, Junichi
    Sugamura, Koichi
    Maeda, Hirofumi
    Iwashita, Satomi
    Jinnouchi, Hideaki
    Matsui, Kunihiko
    Ogawa, Hisao
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 173 (03) : 481 - 486
  • [22] Prevention of Cardiovascular Events in Patients With Chronic Kidney Disease
    Terpening, Chris M. M.
    ANNALS OF PHARMACOTHERAPY, 2023, 57 (12) : 1425 - 1435
  • [23] Long-term risks of cardiovascular events in patients with chronic kidney disease who survived sepsis
    Chu, Hsi
    Chen, Yung-Tai
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [24] CHRONIC KIDNEY DISEASE, DIABETES MELLITUS AND CARDIOVASCULAR DISEASE: RISKS AND COMMONALITIES
    Suckling, Rebecca
    Gallagher, Hugh
    JOURNAL OF RENAL CARE, 2012, 38 : 4 - 11
  • [25] Urine Kidney Injury Biomarkers and Risks of Cardiovascular Disease Events and All-Cause Death: The CRIC Study
    Park, Meyeon
    Hsu, Chi-yuan
    Co, Alan S.
    Feldman, Harold I.
    Xie, Dawei
    Zhang, Xiaoming
    Mifflin, Theodore
    Waikar, Sushrut S.
    Sabbisetti, Venkata S.
    Bonventre, Joseph V.
    Coresh, Josef
    Nelson, Robert C.
    Kimmel, Paul L.
    Kusek, John W.
    Rahman, Mahboob
    Schelling, Jeffrey R.
    Vasan, Ramachandran S.
    Liu, Kathleen D.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 12 (05): : 761 - 771
  • [26] Plasma proenkephalin (pro-ENK) in the prediction of cardiovascular death and hospitalization in patients with dyspnea and chronic kidney disease
    Chan, JJeffrey
    Iqbal, Ni
    Maisel, A. M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 342 - 342
  • [27] Cardiovascular events in patients with deferred lesions and chronic kidney disease
    Hata, Takehiro
    Otsuki, Hisao
    Arashi, Hiroyuki
    Nakao, Masashi
    Yamaguchi, Junichi
    HEART AND VESSELS, 2023, 38 (11) : 1364 - 1370
  • [28] Bone Markers Predict Cardiovascular Events in Chronic Kidney Disease
    Fahrleitner-Pammer, Astrid
    Herberth, Johann
    Browning, Steven R.
    Obermayer-Pietsch, Barbara
    Wirnsberger, Gerhard
    Holzer, Herwig
    Dobnig, Harald
    Malluche, Hartmut H.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 (11) : 1850 - 1858
  • [29] Effect of pravastatin on cardiovascular events in people with chronic kidney disease
    Tonelli, M
    Isles, C
    Curhan, GC
    Tonkin, A
    Pfeffer, MA
    Shepherd, J
    Sacks, FM
    Furberg, C
    Cobbe, SM
    Simes, J
    Craven, T
    West, M
    CIRCULATION, 2004, 110 (12) : 1557 - 1563
  • [30] CHRONIC KIDNEY DISEASE AS A RISK FACTOR FOR CARDIOVASCULAR EVENTS OR MORTALITY
    Bowman, K.
    Ble, A.
    Delgado, J.
    Melzer, D.
    GERONTOLOGIST, 2015, 55 : 25 - 25